Cerenome Statistics
Want to see CNSY full AI Analyst Report?
Cerenome (CNSY) Stock Statistics & Valuation Metrics
Total Valuation
Cerenome has a market cap or net worth of $7.21M. The enterprise value is $13.26M.
- Market Cap
- $7.21M
- Enterprise Value
- $13.26M
Share Statistics
Cerenome has 7,589,774 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 7,589,774
- Owned by Insiders
- 1.12%
- Owned by Institutions
- 10.37%
Financial Efficiency
Cerenome’s return on equity (ROE) is -5.60 and return on invested capital (ROIC) is -317.58%.
- Return on Equity (ROE)
- -5.60
- Return on Assets (ROA)
- -1.37
- Return on Invested Capital (ROIC)
- -317.58%
- Return on Capital Employed (ROCE)
- -3.81
- Revenue Per Employee
- 186.18K
- Profits Per Employee
- -799.50K
- Employee Count
- 28
- Asset Turnover
- 0.32
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Cerenome is -0.00. Cerenome’s PEG ratio is 0.00.
- PE Ratio
- -0.00
- PS Ratio
- 1.72
- PB Ratio
- 1.18
- Price to FCF
- -0.31
- Price to Operating Cash Flow
- -0.29
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Cerenome had revenue of 5.21M and earned -22.39M in profits. Earnings per share was -7.19.
- Revenue
- 5.21M
- Gross Profit
- 4.77M
- Operating Income
- -15.30M
- Pretax Income
- -22.39M
- Net Income
- -22.39M
- EBITDA
- -18.33M
- Earnings Per Share (EPS)
- -7.19
Cash Flow
In the last 12 months, operating cash flow was -27.30M and capital expenditures -1.40M, giving a free cash flow of -28.70M billion.
- Operating Cash Flow
- -27.30M
- Free Cash Flow
- -28.70M
- Free Cash Flow per Share
- -3.48
Dividends & Yields
Cerenome pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -326.54%
- Earnings Yield
- -405.36%
Stock Price Statistics
- Beta
- 2.40
- 52-Week Price Change
- -92.74%
- 50-Day Moving Average
- 1.74
- 200-Day Moving Average
- 4.33
- Relative Strength Index (RSI)
- 37.38
- Average Volume (3m)
- 777.11K
Important Dates
Cerenome upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Cerenome as a current ratio of 1.23, with Debt / Equity ratio of 20.55%
- Current Ratio
- 1.23
- Quick Ratio
- 1.23
- Debt to Market Cap
- 0.07
- Net Debt to EBITDA
- 0.43
- Interest Coverage Ratio
- -4.24
Taxes
In the past 12 months, Cerenome has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Cerenome EV to EBITDA ratio is -0.22, with an EV/FCF ratio of -0.21.
- EV to Sales
- 1.16
- EV to EBITDA
- -0.22
- EV to Free Cash Flow
- -0.21
- EV to Operating Cash Flow
- -0.22
Balance Sheet
Cerenome has $4.87M in cash and marketable securities with $3.98M in debt, giving a net cash position of $890.00K billion.
- Cash & Marketable Securities
- $4.87M
- Total Debt
- $3.98M
- Net Cash
- $890.00K
- Net Cash Per Share
- $0.12
- Tangible Book Value Per Share
- ―
Margins
Gross margin is 89.58%, with operating margin of -628.12%, and net profit margin of -620.70%.
- Gross Margin
- 89.58%
- Operating Margin
- -628.12%
- Pretax Margin
- -620.70%
- Net Profit Margin
- -620.70%
- EBITDA Margin
- -531.88%
- EBIT Margin
- -542.30%
Analyst Forecast
The average price target for Cerenome is $28.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $28.67
- Price Target Upside
- 2917.54% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- -32.90%
- EPS Growth Forecast
- 90.34%
Scores
- Smart Score
- ―
- AI Score
- 41

